Exact Mass: 354.13462680000004
Exact Mass Matches: 354.13462680000004
Found 103 metabolites which its exact mass value is equals to given mass value 354.13462680000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
FUSARENON X
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Methyl (R)-8-Hydroxy-9-decene-4,6-diynoate glucoside
Methyl (R)-8-Hydroxy-9-decene-4,6-diynoate glucoside is found in root vegetables. Methyl (R)-8-Hydroxy-9-decene-4,6-diynoate glucoside is a constituent of Helianthus tuberosus (Jerusalem artichoke). Constituent of Helianthus tuberosus (Jerusalem artichoke). Methyl (R)-8-Hydroxy-9-decene-4,6-diynoate glucoside is found in root vegetables.
Methyl helianthenoate F glucoside
Methyl helianthenoate F glucoside is found in root vegetables. Methyl helianthenoate F glucoside is a constituent of Helianthus tuberosus (Jerusalem artichoke). Constituent of Helianthus tuberosus (Jerusalem artichoke). Methyl helianthenoate F glucoside is found in root vegetables.
1,2-Bis(6-methoxy-1h-benzimidazol-2-yl)ethane-1,2-diol
C18H18N4O4 (354.13279880000005)
Benzamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, trans-
C18H24Cl2N2O (354.12655939999996)
FUSARENON X
Isofezolac
C23H18N2O2 (354.13682079999995)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Hydroprotopine
C20H20NO5+ (354.13414100000006)
2-[[N-Methyl-N-(5-guanidino-2-aminopentanoyl)hydrazino]phosphonyl]-2-hydroxyacetic acid methyl ester
1,2-Methylenedioxy-4-methoxy-5-allyl-phen-3-yl ??-D-glucopyranoside
7-hydroxy-5-methoxy-4,6-dimethyl-7-O-alpha-L-rhamnosylphthalide
ethyl 5-O-trans-feruloyl-alpha-L-arabinofuranoside
O-beta-D-Glucopyranoside-3-(3-Hydroxypropyl)phthalide|pediglucoside
Fusarenone X
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE Reference Standard (Level 1)
Fusarenon-X
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Methyl helianthenoate F glucoside
Methyl (R)-8-Hydroxy-9-decene-4,6-diynoate glucoside
3-[6-(ETHOXYCARBONYL)-3-ETHYL-2-METHYL-3H-BENZIMIDAZOL-1-IUM-1-YL]PROPANE-1-SULFONATE
C16H22N2O5S (354.12493620000004)
4-[carboxy-(3-chloro-phenyl)-methyl]-piperazine-1-carboxylic acid tert-butyl ester hydrochloride
C17H23ClN2O4 (354.13462680000004)
Propanedioic acid,2-(3,4,5-trimethoxybenzoyl)-, 1,3-diethyl ester
Thiourea, N-(2,3-dimethylphenyl)-N-[4-(4-fluorophenyl)-5-methyl-1H-pyrazol-3-yl]- (9CI)
4-Methyl 1-(2-methyl-2-propanyl) 4-[(trifluoroacetyl)amino]-1,4-p iperidinedicarboxylate
BENZOFURAN-2-YL-[4-(4-FLUORO-PHENYL)-PIPERAZIN-1-YL]-ACETIC ACID
C20H19FN2O3 (354.13796360000003)
3-(3-CARBAMOYL-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
C16H22N2O5S (354.12493620000004)
3-(4-CARBAMOYL-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
C16H22N2O5S (354.12493620000004)
4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-ylsulfonyl)morpholine
sodium,[(8R,9S,13S,14S)-2,4,16,16-tetradeuterio-13-methyl-17-oxo-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-3-yl] sulfate
Methyl 4-(4-Boc-1-piperazinyl)-2-chlorobenzoate
C17H23ClN2O4 (354.13462680000004)
N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)cyclopropanesulfonamide
6-(Phthalimidomethyl)-6,11-dihydro-5H-dibenz-[b,e]azepine (PMDAP)
C23H18N2O2 (354.13682079999995)
1-Trityl-1H-imidazole-4-carboxylic acid
C23H18N2O2 (354.13682079999995)
N-(4-amino-2-methyl-pyrimidin-5-ylmethyl)-N-(2-ethoxycarbonylsulfanyl-4-hydroxy-1-methyl-but-1-enyl)-formamide
C15H22N4O4S (354.13616920000004)
Benzoic acid, 4-[1-[(2,4-diaMino-6-pteridinyl)Methyl]-3-butyn-1-yl]-, lithiuM salt (1:1)
Methyl 4-(4-Boc-1-piperazinyl)-3-chlorobenzoate
C17H23ClN2O4 (354.13462680000004)
2-Diphenylacetyl-1,3-indandione-1-hydrazone
C23H18N2O2 (354.13682079999995)
3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzamide
C18H24Cl2N2O (354.12655939999996)
1,2-Bis(6-methoxy-1h-benzimidazol-2-yl)ethane-1,2-diol
C18H18N4O4 (354.13279880000005)
Benzamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, cis-
C18H24Cl2N2O (354.12655939999996)
D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
2-[[3-Methyl-7-(3-methylbutyl)-2,6-dioxo-8-purinyl]thio]propanoic acid methyl ester
C15H22N4O4S (354.13616920000004)
3-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-(3-pyridinyl)propanamide
C18H18N4O4 (354.13279880000005)
N-(2-oxolanylmethyl)-2-(7-oxo-3-phenyl-6-triazolo[4,5-d]pyrimidinyl)acetamide
[1-(3-Chloro-2-formyl-phenylcarbamoyl)-2-methyl-propyl]-carbamic acid tert-butyl ester
C17H23ClN2O4 (354.13462680000004)
2-(3,4-Dichlorophenyl)-1-[2-(1-pyrrolidinylmethyl)-1-piperidinyl]ethanone
C18H24Cl2N2O (354.12655939999996)
3-[(2-Amino-benzoyl)-hydrazono]-N-benzo[1,3]dioxol-5-yl-butyramide
C18H18N4O4 (354.13279880000005)
N-[(4R)-1-(2,4-difluorophenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2-pyridinecarboxamide
C19H16F2N4O (354.12921099999994)
N-[4-(cyanomethyl)phenyl]-4-cyclohexylbenzenesulfonamide
2-{[3-cyano-4-(methoxymethyl)-6-methylpyridin-2-yl]oxy}-N-[(1E)-(2-hydroxyphenyl)methylene]acetohydrazide
C18H18N4O4 (354.13279880000005)
N-[(4S)-1-(2,4-difluorophenyl)-4,5,6,7-tetrahydroindazol-4-yl]-2-pyridinecarboxamide
C19H16F2N4O (354.12921099999994)
2-[(2S,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide
C16H22N2O5S (354.12493620000004)
2-[(2S,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide
C16H22N2O5S (354.12493620000004)
2-[(2R,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide
C16H22N2O5S (354.12493620000004)
2-[(2S,3S,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide
C16H22N2O5S (354.12493620000004)
2-[(2R,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide
C16H22N2O5S (354.12493620000004)
2-[(2R,3R,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide
C16H22N2O5S (354.12493620000004)
3,4,5-Trihydroxy-6-[3-hydroxy-2-(3-methylbut-2-enyl)phenoxy]oxane-2-carboxylic acid
6-(2-Benzyl-3-oxobutoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) octanoate
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) heptanoate
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) hexanoate
Isofezolac
C23H18N2O2 (354.13682079999995)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
ER-000444793
C23H18N2O2 (354.13682079999995)
ER-000444793 is a potent inhibitor of mitochondrial permeability transition pore (mPTP) opening. ER-000444793 inhibits mPTP with an IC50 of 2.8?μM.
KI-7
C23H18N2O2 (354.13682079999995)
KI-7 is an A2B adenosine receptor positive allosteric modulator. KI-7 potentiates the cAMP accumulation induced by the non-selective A2B adenosine receptor agonist NECA (EC50=445.8 nM). KI-7 also potentiates the cAMP accumulation induced by the selective A2B adenosine receptor agonist BAY 60-6583 as well as by adenosine with EC50s of 2390 nM and 2550 nM, respectively[1][2].
MLS1547
MLS1547 is a highly efficacious G protein-biased dopamine D2 receptor (D2R) agonist (Ki=1.2 μM). MLS1547 stimulates D2R G protein-mediated signaling (EC50=0.37 μM in a calcium mobilization assay). MLS1547 acts as an antagonist for dopamine (DA)-stimulated β-arrestin recruitment to the D2R (IC50=9.9 μM)[1][2].